Literature DB >> 18829876

Bipolar drug development: are we getting closer to the real world?

Joseph R Calabrese, David E Kemp.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18829876     DOI: 10.1176/appi.ajp.2008.08060967

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  2 in total

Review 1.  Long-acting risperidone: a review of its role in the treatment of bipolar disorder.

Authors:  David E Kemp; Fatih Canan; Benjamin I Goldstein; Roger S McIntyre
Journal:  Adv Ther       Date:  2009-06-26       Impact factor: 3.845

2.  Young Mania Rating Scale: how to interpret the numbers? Determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort.

Authors:  Michael Lukasiewicz; Stephanie Gerard; Adeline Besnard; Bruno Falissard; Elena Perrin; Helene Sapin; Mauricio Tohen; Catherine Reed; Jean-Michel Azorin
Journal:  Int J Methods Psychiatr Res       Date:  2013-03-21       Impact factor: 4.035

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.